[go: up one dir, main page]

AU2600499A - Methods and compositions comprising the use of blocked b-amyloid peptide - Google Patents

Methods and compositions comprising the use of blocked b-amyloid peptide

Info

Publication number
AU2600499A
AU2600499A AU26004/99A AU2600499A AU2600499A AU 2600499 A AU2600499 A AU 2600499A AU 26004/99 A AU26004/99 A AU 26004/99A AU 2600499 A AU2600499 A AU 2600499A AU 2600499 A AU2600499 A AU 2600499A
Authority
AU
Australia
Prior art keywords
blocked
compositions
methods
amyloid peptide
amyloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26004/99A
Inventor
Timothy S. Burkoth
David G. Lynn
Stephen C. Meredith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arch Development Corp
Original Assignee
Arch Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arch Development Corp filed Critical Arch Development Corp
Publication of AU2600499A publication Critical patent/AU2600499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU26004/99A 1998-02-13 1999-02-12 Methods and compositions comprising the use of blocked b-amyloid peptide Abandoned AU2600499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7465898P 1998-02-13 1998-02-13
US60074658 1998-02-13
PCT/US1999/003231 WO1999041279A2 (en) 1998-02-13 1999-02-12 Methods and compositions comprising the use of blocked b-amyloid peptide

Publications (1)

Publication Number Publication Date
AU2600499A true AU2600499A (en) 1999-08-30

Family

ID=22120866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26004/99A Abandoned AU2600499A (en) 1998-02-13 1999-02-12 Methods and compositions comprising the use of blocked b-amyloid peptide

Country Status (2)

Country Link
AU (1) AU2600499A (en)
WO (1) WO1999041279A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
JP4235544B2 (en) 2001-05-31 2009-03-11 アドライフ インコーポレーティッド Defect folding protein sensor method
US8663650B2 (en) * 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US7807171B2 (en) 2003-07-25 2010-10-05 Ac Immune Sa Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
JP4934433B2 (en) 2004-02-20 2012-05-16 エーシー イミューン ソシエテ アノニム Methods and compositions comprising supramolecular constructs
MX2007009819A (en) 2005-02-15 2007-11-07 Adlyfe Inc Method for detecting misfolded proteins and prions.
WO2008013859A2 (en) * 2006-07-28 2008-01-31 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
WO2008070284A2 (en) * 2006-10-16 2008-06-12 Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute Amyloid beta peptides and methods of uses thereof
EP3527220A1 (en) 2010-08-12 2019-08-21 AC Immune S.A. Vaccine engineering
WO2012055933A1 (en) 2010-10-26 2012-05-03 Ac Immune S.A. Liposome-based construct comprising a peptide modified through hydrophobic moieties
WO2013065343A1 (en) * 2011-10-31 2013-05-10 株式会社 島津製作所 Peptide-hinge-free flexible antibody-like molecule
WO2021100744A1 (en) * 2019-11-19 2021-05-27 Ｔａｏヘルスライフファーマ株式会社 CROSSLINKED PRODUCT OF AMYLOID-β PROTEIN (Aβ) ABLE TO BE SUBSTITUTE FOR AMYLOSPHEROID (ASPD), AND ANALYSIS OF ASPD

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434050A (en) * 1991-08-13 1995-07-18 Regents Of The University Of Minnesota Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
US6319498B1 (en) * 1995-03-14 2001-11-20 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation

Also Published As

Publication number Publication date
WO1999041279A3 (en) 1999-10-28
WO1999041279A2 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
IL138453A0 (en) Peptide compositions and formulations and use of same
AU5870999A (en) Hand cleaner compositions and uses
HUP0103562A3 (en) Novel compositions and use
AU2349399A (en) R-lansoprazole compositions and methods
AU1800600A (en) Ume extract having medicinal effects and compositions containing the same
AU2003201281A1 (en) Antimicrobial peptides and derived metapeptides
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
AU2600499A (en) Methods and compositions comprising the use of blocked b-amyloid peptide
AU1915399A (en) Cs-1 peptidomimetics, compositions and methods of using the same
GB9811168D0 (en) Direct hair-colouring compositions and the use thereof
AU1152601A (en) Compositions and their use
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
IL125908A0 (en) Peptides and pharmaceutical compositions comprising same
AU9061798A (en) Protease variants and compositions
EP1139981A4 (en) Compositions and methods of using the same
AU2183899A (en) Isoflavane derivatives and immunopotentiating compositions containing the same
AU4207899A (en) Lentiviral vector compositions and methods of use
AU3558799A (en) Flutamide compositions and preparations
AU2880699A (en) Pharmaceutical compositions and methods for use
AU3283299A (en) Probiotic composition and the use thereof
AU3900499A (en) (+)-hydroxyrisperidone compositions and methods
AU3411999A (en) Novel rnase-like protein and its use
AU3061199A (en) Skin treatment compositions and the use thereof
AU9061898A (en) Protease variants and compositions
AU1798100A (en) Use of peptide

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase